These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 24964988)
1. Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy". van der Most R; Wettendorff M; Innis B; Hanon E Sci Transl Med; 2014 Jun; 6(242):242le3. PubMed ID: 24964988 [TBL] [Abstract][Full Text] [Related]
2. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159 [TBL] [Abstract][Full Text] [Related]
3. Autoimmunity: a new clue to sleepiness. Kugelberg E Nat Rev Immunol; 2014 Feb; 14(2):66-7. PubMed ID: 24445664 [No Abstract] [Full Text] [Related]
4. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Luo G; Ambati A; Lin L; Bonvalet M; Partinen M; Ji X; Maecker HT; Mignot EJ Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12323-E12332. PubMed ID: 30541895 [TBL] [Abstract][Full Text] [Related]
5. H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls. Schinkelshoek MS; Fronczek R; Kooy-Winkelaar EMC; Petersen J; Reid HH; van der Heide A; Drijfhout JW; Rossjohn J; Lammers GJ; Koning F J Neuroimmunol; 2019 Jul; 332():167-175. PubMed ID: 31048269 [TBL] [Abstract][Full Text] [Related]
9. T cell reactivity to regulatory factor X4 in type 1 narcolepsy. Luo G; Yogeshwar S; Lin L; Mignot EJ Sci Rep; 2021 Apr; 11(1):7841. PubMed ID: 33837283 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination. van der Heide A; Hegeman-Kleinn IM; Peeters E; Lammers GJ; Fronczek R J Neuroimmunol; 2015 Jun; 283():58-62. PubMed ID: 26004157 [TBL] [Abstract][Full Text] [Related]
11. Genetic association, seasonal infections and autoimmune basis of narcolepsy. Singh AK; Mahlios J; Mignot E J Autoimmun; 2013 Jun; 43():26-31. PubMed ID: 23497937 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560 [TBL] [Abstract][Full Text] [Related]
13. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1. Vuorela A; Freitag TL; Leskinen K; Pessa H; Härkönen T; Stracenski I; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Ilonen J; Knip M; Vaheri A; Partinen M; Saavalainen P; Meri S; Vaarala O Nat Commun; 2021 Apr; 12(1):2283. PubMed ID: 33863907 [TBL] [Abstract][Full Text] [Related]
14. CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1. Ramberger M; Högl B; Stefani A; Mitterling T; Reindl M; Lutterotti A Sleep; 2017 Mar; 40(3):. PubMed ID: 28364420 [TBL] [Abstract][Full Text] [Related]
15. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681 [TBL] [Abstract][Full Text] [Related]
16. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Latorre D; Kallweit U; Armentani E; Foglierini M; Mele F; Cassotta A; Jovic S; Jarrossay D; Mathis J; Zellini F; Becher B; Lanzavecchia A; Khatami R; Manconi M; Tafti M; Bassetti CL; Sallusto F Nature; 2018 Oct; 562(7725):63-68. PubMed ID: 30232458 [TBL] [Abstract][Full Text] [Related]
17. [Narcolepsy: From the discovery of a wake promoting peptide to autoimmune T cell biology and molecular mimicry with flu epitopes]. Ravel JM; Mignot EJM Biol Aujourdhui; 2019; 213(3-4):87-108. PubMed ID: 31829930 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling. Sadam H; Pihlak A; Kivil A; Pihelgas S; Jaago M; Adler P; Vilo J; Vapalahti O; Neuman T; Lindholm D; Partinen M; Vaheri A; Palm K EBioMedicine; 2018 Mar; 29():47-59. PubMed ID: 29449194 [TBL] [Abstract][Full Text] [Related]
19. Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB/c mice. Lu IN; Farinelle S; Sausy A; Muller CP Cell Mol Immunol; 2017 Jun; 14(6):511-520. PubMed ID: 27157498 [TBL] [Abstract][Full Text] [Related]
20. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls. Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å Viral Immunol; 2017 Oct; 30(8):590-600. PubMed ID: 28796576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]